Crinetics Pharmaceuticals has a total of 587 patents globally, out of which 211 have been granted. Of these 587 patents, 87.39% patents are active. The United States of America is where Crinetics Pharmaceuticals has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Crinetics Pharmaceuticals.
Founded in 2008, Crinetics Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics for endocrine diseases and endocrine-related tumors. The company’s pipeline includes innovative oral therapies targeting rare endocrine disorders, including acromegaly, congenital adrenal hyperplasia (CAH), and Cushing’s syndrome. Crinetics is committed to developing differentiated treatments that improve patient outcomes through precision-targeted endocrine therapies while addressing significant unmet medical needs.
In July 2026, Vertex Pharmaceuticals agreed to acquire Crinetics Pharmaceuticals for approximately $10 billion to expand its presence in endocrinology and rare diseases. The acquisition strengthens Vertex’s commercial portfolio with PALSONIFY (paltusotine), the first once-daily oral therapy for acromegaly, and advances its late-stage pipeline with atumelnant, a Phase 3 candidate for congenital adrenal hyperplasia (CAH), while accelerating Vertex’s long-term growth strategy in endocrine therapeutics.
Do read about some of the most notable patents of Crinetics Pharmaceuticals covered in this article. You can also explore Crinetics Pharmaceuticals’ patent portfolio, worldwide patent filing activity, patent filing trends over the years, and many other statistics related to its patent portfolio.
How many patents does Crinetics Pharmaceuticals have?
Crinetics Pharmaceuticals has a total of 587 patents globally. These patents belong to 44 unique patent families. Out of 587 patents, 513 patents are active.
How Many Patents did Crinetics Pharmaceuticals File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Crinetics Pharmaceuticals Applications Filed | Crinetics Pharmaceuticals Patents Granted |
| 2026 | 14 | 21 |
| 2025 | 53 | 69 |
| 2024 | 86 | 20 |
| 2023 | 75 | 36 |
| 2022 | 78 | 36 |
| 2021 | 42 | 15 |
| 2020 | 83 | 8 |
| 2019 | 89 | 3 |
| 2018 | 21 | 3 |
| 2017 | 36 | – |
| 2016 | 10 | – |
How many Crinetics Pharmaceuticals patents are Alive/Dead?
Worldwide Patents
How Many Patents did Crinetics Pharmaceuticals File in Different Countries?
Top Countries in which Crinetics Pharmaceuticals Filed Patents
| Country | Patent |
| United States of America | 54 |
| Japan | 34 |
| Europe (EPO) | 33 |
| China | 24 |
| Singapore | 22 |
| Hong Kong (S.A.R.) | 21 |
| Taiwan | 20 |
| Israel | 19 |
| Australia | 18 |
| Korea (South) | 18 |
| Eurasian | 18 |
| Mexico | 18 |
| Canada | 18 |
| South Africa | 17 |
| India | 15 |
| Brazil | 14 |
| New Zealand | 14 |
| Indonesia | 14 |
| Germany | 10 |
| Austria | 9 |
| Colombia | 9 |
| Chile | 8 |
| Viet Nam | 8 |
| Argentina | 7 |
| Peru | 7 |
| Philippines | 6 |
| United Arab Emirates | 6 |
| Spain | 6 |
| Norway | 6 |
| Portugal | 5 |
| Turkey | 5 |
| Macao | 5 |
| Pakistan | 5 |
| Denmark | 5 |
| Poland | 5 |
| Slovenia | 5 |
| Ukraine | 4 |
| Serbia | 4 |
| Croatia | 4 |
| Italy | 4 |
| Hungary | 4 |
| Finland | 3 |
| Malta | 3 |
| Morocco | 3 |
| Republic of Moldova | 3 |
| Malaysia | 3 |
| Lithuania | 3 |
| Slovakia | 2 |
| Albania | 1 |
| Bangladesh | 1 |
| Cyprus | 1 |
| Costa Rica | 1 |
| Uruguay | 1 |
Stay Updated on Patent Activity
Patent activity moves fast. With Elixir, monitor new filings, track competitors, and get timely alerts on critical IP developments. Book an Elixir Demo
Where are Research Centres of Crinetics Pharmaceuticals Patents Located?
10 Best Crinetics Pharmaceuticals Patents
WO2018013676A1 is the most popular patent in the Crinetics Pharmaceuticals portfolio. It has received 33 citations so far from companies like Companies, Basecamp Bio Inc, and Assia Chemical Industries.
Below is the list of 10 most cited patents of Crinetics Pharmaceuticals:
| Publication Number | Citation Count |
| WO2018013676A1 | 33 |
| WO2018170284A1 | 25 |
| WO2017003723A1 | 21 |
| WO2021133563A1 | 18 |
| WO2021091788A1 | 17 |
| WO2019236699A1 | 17 |
| WO2019143718A1 | 16 |
| US10696689B2 | 15 |
| WO2020061046A1 | 14 |
| WO2021126693A1 | 13 |
What Percentage of Crinetics Pharmaceuticals US Patent Applications Were Granted?
Crinetics Pharmaceuticals (Excluding its subsidiaries) has filed 49 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 25 have been granted leading to a grant rate of 73.53%.
Below are the key stats of Crinetics Pharmaceuticals patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Crinetics Pharmaceuticals?
| Law Firm | Total Applications | Success Rate |
| Crinetics Pharmaceuticals (Inhouse IP Dept) | 43 | 77.42% |
| Wilson Sonsini Goodrich & Rosati | 4 | 33.33% |
| Radionetics Oncology Inc Wsgr | 2 | 0% |
What are Crinetics Pharmaceuticals key innovation segments?
What Technologies are Covered by Crinetics Pharmaceuticals?
The chart below distributes patents filed by Crinetics Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Crinetics Pharmaceuticals thinks it’s important to protect particular technological inventions.
R&D Focus: How has Crinetics Pharmaceuticals search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Crinetics Pharmaceuticals?
